Vivek Subbiah/LinkedIn
Apr 22, 2025, 17:31
Vivek Subbiah: It’s moments like these that remind me why I do what I do
Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn:
“Feeling incredibly grateful and touched!
One of my amazing patients surprised me today with zebra socks after reading my American Society of Clinical Oncology (ASCO) Educational book on,
‘Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras.’
Her thoughtful gesture truly made my day! It’s moments like these that remind me why I do what I do.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 23:57